About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,029 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,029 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 801-820 of 8,029 trials

Active not recruitingOsimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung CancerThe present study will evaluate the use of osimertinib as 1st line therapy for patients with advanced EGFR positive non-small cell lung cancer who are treated at Hellenic…NCT05127382·Athens UnknownA Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung CancerTo evaluate the safety and tolerability of carbognilumab combined with chemotherapy as the first-line treatment for patients with STK11 mutated advanced or postoperative recurrent…NCT06331650·Guangdong, Guangzhou CompletedCombination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003317·Scottsdale, Arizona and 15 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedOsimertinib and Bevacizumab as Treatment for EGFR-mutant Lung CancersThe purpose of this study is to test the safety of combining the drugs osimertinib and bevacizumab at different dose levels.NCT02803203·Basking Ridge, New Jersey and 6 others

RecruitingJAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C MutationThis Phase 3 study will evaluate the efficacy of JAB-21822+JAB-3312 versus tislelizumab (PD-1 Ab) combined with pemetrexed+carboplatin as the first line treatment in subjects with…NCT06416410·Hefei, Anhui and 36 others

TerminatedCAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract TumorsTo assess the anti-tumor activity of CAP7.1 based on the observed objective response rate and rate of disease stabilization, as defined by the below primary and secondary…NCT02094560·Berlin

RecruitingSafety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung CancerThis multicenter retrospective real-world study aims to evaluate the safety, efficacy and survival outcomes of neoadjuvant/induction immunotherapy in patients with non-small cell…NCT06926179·Beijing, Beijing Municipality and 3 others

CompletedStudy of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.The Drugs Controller General of India (DCGI) granted approval for Rahika® (capmatinib) film-coated tablets (150 mg and 200 mg) for the treatment of adult patients with advanced or…NCT05110196·Gujarat, Gujarat and 14 others

WithdrawnPazopanib and Paclitaxel for Non-Small Cell Lung CancerLung cancer is the leading cause of cancer worldwide with approximately 1.2 million new cases each year.NCT01179269

UnknownA Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung CancerThe main purpose of this study is to explore if the combination of autologous NK cell infusion and chemotherapy can increase the therapeutic efficiency in the treatment of…NCT02734524·Chongqing, Chongqing Municipality

CompletedDose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid TumorsThe purpose of this study is to determine if TH-302, in combination with A) Gemcitabine, or B) Docetaxel or C) Pemetrexed methotrexate, are safe and effective in the treatment of…NCT00743379·Scottsdale, Arizona and 10 others

UnknownMILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung CancerThe purpose of this study is to evaluate the addition of cisplatin to first-line chemotherapy with gemcitabine in elderly patients with non small cell lung cancer in terms of…NCT01405586·Genova, GE and 48 others

RecruitingPhase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC RegimenAim of this phase 2 study is to explore the safety and efficacy of thoracic re-irradiation +/- SBRT to oligometastases (\<3) followed after an interval of 2 weeks by durvalumab…NCT06680050·Brescia and 8 others

UnknownTemozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain MetastasesWith the improvement of systemic therapeutic effect(especially in the population with driver gene mutation), the incidence of brain metastases had significantly increased.NCT03732482

CompletedPhase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet ChemotherapyThis study is multicenter, randomized, double-blinded, placebo-controlled Phase II study comparing vandetanib (300mg daily) plus best supportive care (BSC) to placebo plus BSC as…NCT00777179·Cheongju-si, Republic of Korea and 4 others

RecruitingImpact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable MutationsEvidence suggests that appropriately selected older adults can tolerate standard-dose chemotherapy and achieve survival outcomes comparable to younger patients.NCT07369596·Hong Kong and 3 others

UnknownEffect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung CancerThis Study evaluate the effect of Polymorphism in the Excision repair cross-complementing group 5 (ERCC5) (rs1047768 and rs751402) gene on the clinical outcome of Platinum-based…NCT03154242·Cairo

UnknownBiweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) PatientsThere is little information of Eastern Cooperative Oncology Group (ECOG) performance status (PS) 2 patients analyzed in the clinical trials.NCT00906061·Alcoy, Alicante and 11 others

RecruitingT Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerBackground: The NCI Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them in the laboratory in large…NCT02133196·Bethesda, Maryland

Active not recruitingEvaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.This study aimed to investigate the role of impedance cardiography (ICG) in evaluating hemodynamic changes during the 6-minute walk test (6MWT) in patients with locally advanced…NCT06277388·Guangzhou, Guangdong

PreviousPage 41 of 402Next